The abstract is read at the publisher; the summary is JClub's.
Spontaneous menopause in rigorously staged women (n=80; STRAW+10; ages 43–58) is linked to dysregulated inflammatory, synaptic, metabolic, and Alzheimer’s disease proteomic processes that track more strongly with hormones than age.
- Why it matters: Menopause is implicated in later neurodegenerative risk, but the biological pathways connecting midlife hormonal change to brain aging and dementia risk are not well defined.
- What they did: Using serum NULISAseq proteomics in pre-, peri-, and postmenopausal women, then validating with plasma Olink proteomics in age-matched samples (n=2,814), the study tested menopause-associated proteomic shifts and related them to organ and cell aging, including brain aging.
- The result: Across four independent cohorts of older women (total n=11,925; average age 60.7–72.1), higher menopause proteomic scores are consistently associated with cognitive aging and dementia risk, suggesting biomarker or therapeutic target potential for midlife brain health.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.